<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" dtd-version="1.3" xml:lang="EN" article-type="rapid-communication"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Chem Res Toxicol</journal-id><journal-id journal-id-type="iso-abbrev">Chem Res Toxicol</journal-id><journal-id journal-id-type="publisher-id">tx</journal-id><journal-id journal-id-type="coden">crtoec</journal-id><journal-title-group><journal-title>Chemical Research in Toxicology</journal-title></journal-title-group><issn pub-type="ppub">0893-228X</issn><issn pub-type="epub">1520-5010</issn><publisher><publisher-name>American Chemical Society</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40331678</article-id><article-id pub-id-type="pmc">PMC12093358</article-id>
<article-id pub-id-type="doi">10.1021/acs.chemrestox.5c00068</article-id><article-categories><subj-group><subject>Communication</subject></subj-group></article-categories><title-group><article-title>Identification
and Structural Elucidation of a Novel
Pyrrolidinophenone-Based Designer Drug on the Illicit Market: &#x003b1;-BPVP</article-title></title-group><contrib-group><contrib contrib-type="author" id="ath1"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-5049-7321</contrib-id><name><surname>Casati</surname><given-names>Sara</given-names></name><xref rid="aff1" ref-type="aff">&#x02020;</xref><xref rid="aff2" ref-type="aff">#</xref></contrib><contrib contrib-type="author" id="ath2"><name><surname>Bergamaschi</surname><given-names>Roberta F.</given-names></name><xref rid="aff1" ref-type="aff">&#x02020;</xref></contrib><contrib contrib-type="author" id="ath3"><name><surname>Primavera</surname><given-names>Riccardo</given-names></name><xref rid="aff3" ref-type="aff">$</xref></contrib><contrib contrib-type="author" id="ath4"><name><surname>Ravelli</surname><given-names>Alessandro</given-names></name><xref rid="aff1" ref-type="aff">&#x02020;</xref></contrib><contrib contrib-type="author" id="ath5"><name><surname>Lavota</surname><given-names>Ivana</given-names></name><xref rid="aff4" ref-type="aff">&#x000b0;</xref></contrib><contrib contrib-type="author" id="ath6"><name><surname>Battistini</surname><given-names>Alessio</given-names></name><xref rid="aff1" ref-type="aff">&#x02020;</xref></contrib><contrib contrib-type="author" id="ath7"><name><surname>Roda</surname><given-names>Gabriella</given-names></name><xref rid="aff6" ref-type="aff">^</xref></contrib><contrib contrib-type="author" id="ath8"><name><surname>Ciccarelli</surname><given-names>Chiara</given-names></name><xref rid="aff5" ref-type="aff">&#x000a3;</xref></contrib><contrib contrib-type="author" id="ath9"><name><surname>Guidotti</surname><given-names>Claudio</given-names></name><xref rid="aff5" ref-type="aff">&#x000a3;</xref></contrib><contrib contrib-type="author" corresp="yes" id="ath10"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-5795-4989</contrib-id><name><surname>Rota</surname><given-names>Paola</given-names></name><xref rid="cor1" ref-type="other">*</xref><xref rid="aff1" ref-type="aff">&#x02020;</xref><xref rid="aff4" ref-type="aff">&#x000b0;</xref></contrib><aff id="aff1"><label>&#x02020;</label>Dipartimento
di Scienze Biomediche, Chirurgiche ed Odontoiatriche, <institution>Universit&#x000e0; degli Studi di Milano</institution>, 20133 Milan, <country>Italy</country></aff><aff id="aff2"><label>#</label><institution>Fondazione
IRCCS Ca&#x02019; Granda Ospedale Maggiore Policlinico</institution>, 20122 Milan, <country>Italy</country></aff><aff id="aff3"><label>$</label>Dipartimento
di Scienze Biomediche per la Salute, <institution>Universit&#x000e0;
degli Studi di Milano</institution>, 20133 Milan, <country>Italy</country></aff><aff id="aff4"><label>&#x000b0;</label><institution>Institute
for Molecular and Translational Cardiology (IMTC)</institution>, San Donato Milanese, 20097 Milan, <country>Italy</country></aff><aff id="aff5"><label>&#x000a3;</label><institution>Gabinetto
Regionale di Polizia Scientifica per la Lombardia, Polizia di Stato</institution>, Via Fatebenefratelli 11, 20121 Milan, <country>Italy</country></aff><aff id="aff6"><label>^</label>Dipartimento
di Scienze Farmaceutiche, <institution>Universit&#x000e0;
degli Studi di Milano</institution>, 20133 Milan, <country>Italy</country></aff></contrib-group><author-notes><corresp id="cor1"><label>*</label><email>paola.rota@unimi.it</email></corresp></author-notes><pub-date pub-type="epub"><day>07</day><month>05</month><year>2025</year></pub-date><pub-date pub-type="collection"><day>19</day><month>05</month><year>2025</year></pub-date><volume>38</volume><issue>5</issue><fpage>808</fpage><lpage>811</lpage><history><date date-type="received"><day>13</day><month>02</month><year>2025</year></date><date date-type="accepted"><day>30</day><month>04</month><year>2025</year></date><date date-type="rev-recd"><day>22</day><month>04</month><year>2025</year></date></history><permissions><copyright-statement>&#x000a9; 2025 The Authors. Published by American Chemical Society</copyright-statement><copyright-year>2025</copyright-year><copyright-holder>The Authors</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p content-type="toc-graphic"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="tx5c00068_0003" id="ab-tgr1"/></p><p>The identification of a new psychoactive substances
(NPS) with
a cathinone structure and a biphenyl substituent, found in seized
powder from the black market, is here reported. By combining analytical
techniques, including 1D and 2D NMR and HRMS, the compound was identified
as 1-([1,1&#x02032;-biphenyl]-4-yl)-2-(pyrrolidin-1-yl)pentan-1-one
(&#x003b1;-BPVP), an &#x003b1;-pyrrolidinopentiophenone (&#x003b1;-PVP)
analogue featuring a biphenyl group instead of the phenyl ring. This
previously unreported molecule raises urgent legal and public health
concerns, which warrants further toxicological investigation.</p></abstract><custom-meta-group><custom-meta><meta-name>document-id-old-9</meta-name><meta-value>tx5c00068</meta-value></custom-meta><custom-meta><meta-name>document-id-new-14</meta-name><meta-value>tx5c00068</meta-value></custom-meta><custom-meta><meta-name>ccc-price</meta-name><meta-value/></custom-meta></custom-meta-group></article-meta></front><body><p id="sec1">The new psychoactive substances
(NPS) phenomenon represents a pivotal challenge compared to traditional
drugs, emerging as a global threat to public health and institutions.<sup><xref ref-type="bibr" rid="ref1">1</xref></sup> Synthetic cathinones and cannabinoids as well
as phenethylamines and piperazines are some examples of NPS classes.
The health risks of novel compounds are largely unknown, with some
posing serious or fatal risks to consumers. Few studies about NPS
toxicity and their correlation between their consumption and psychopathological
symptoms have been conducted;<sup><xref ref-type="bibr" rid="ref2">2</xref>&#x02212;<xref ref-type="bibr" rid="ref4">4</xref></sup> however, research on these substances
is challenging, due to their continuous change and the lack of analytical
certified materials. Other difficult aspects of the NPS phenomenon
regard the recognition from law enforcement during a seizure and the
legislation: NPS are not controlled by international legislative control
conventions; however, in Europe and non-EU countries, some classes
of NPS may be subject to national regulatory measures.<sup><xref ref-type="bibr" rid="ref5">5</xref></sup> For this reason, the market for NPS is constantly expanding
since each year new substances are created to avoid legal controls.
Even though this phenomenon is slow, reports of already encountered
NPS are increasing. Common approaches to identify NPS are gas chromatography
(GC) and liquid chromatography (LC) separation coupled to mass spectrometry
(MS) detection. Moreover, considering the rapid evolution of NPS,
the use of updated libraries is fundamental for the recognition. However,
when new molecules are dropped on the market, the combined use of
different techniques may be required to gather complementary data
supporting the submitted case. In our case, a 38-year-old man was
found dead in his room without any signs of injuries and trauma but
with some paraphernalia and wrappers containing powders around him.
The police seized all and multiple already known NPS (3,4-MDPHP, 3,4-MDiPHP,
&#x003b1;-PCYP and 2-MMC) were identified. However, the fragmentation
of a white powder included in a packet with a tag reporting the name
&#x0201c;a-BPVP&#x0201d; did not match any compounds in the GC&#x02013;MS
libraries. In this case, the elucidation of unknown substances requires
the combined use of high-resolution mass spectrometry (HRMS) and nuclear
magnetic resonance (NMR). Indeed, HRMS data alone may be insufficient
to provide detailed structural information, necessitating the use
of two-dimensional NMR experiments.</p><p>In this paper, we describe
the identification and characterization
of an &#x003b1;-PVP analogue (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>), the &#x003b1;-BPVP in a seized powder by different
analytical techniques, i.e., GC&#x02013;MS with electron impact ionization
(GC-EI/MS), high-resolution accurate-mass Orbitrap mass spectrometry
(HRAM-Orbitrap-MS), and 1D and 2D NMR analyses. Remarkably, we report
the first identification of a previously unknown NPS: 1-([1,1&#x02032;-biphenyl]-4-yl)-2-(pyrrolidin-1-yl)pentan-1-one.
This discovery raises significant legal and health concerns, highlighting
the urgent need for monitoring and further investigation of its toxicological
and public health impact.</p><fig id="fig1" position="float"><label>Figure 1</label><caption><p>Structure of synthetic cathinones: &#x003b1;-PVP
and the new derivatives
&#x003b1;-BPVP.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="tx5c00068_0001" id="gr1" position="float"/></fig><p>The seized powder, labeled &#x0201c;a-BVPV&#x0201d;
on the packaging
as found on the market for psychoactive substances, was initially
analyzed using routine analytical techniques, including GC&#x02013;MS
and quadrupole mass spectrometry, to identify the molecule via database
library matching. The inability to achieve conclusive identification
with these methods necessitated a comprehensive NMR analysis for structural
elucidation.</p><p><sup>1</sup>H NMR analysis was performed in both
CDCl<sub>3</sub> and CDCl<sub>3</sub> with a 1:1 methanol mixture.
Pure chloroform
allowed the observation of the NH proton at downfield regions (12.73
ppm), confirming that the powder was in salt form; on the other hand,
the latter solvent system improved compound solubility and was initially
selected for the complete 1D and 2D characterization.</p><p>The <sup>1</sup>H NMR analysis immediately indicated a cathinonic
structure (<xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>), showing a triplet associated with the hydrogen at the &#x003b1;-carbon
of the carbonyl group at 5.47 ppm (H at C2), an aromatic system, signals
corresponding to an alkyl chain, and peaks consistent with a pyrrolidine
ring (between 3.71 and 3.18 and 2.22&#x02013;2.06 ppm). Notably, by
arbitrarily assigning an integration value of one to the hydrogen
at 5.47 ppm, the analysis confirmed the presence of a pyrrolidine
ring (4H at C1&#x02033;/C4&#x02033; and 4H at C2&#x02033;/C3&#x02033;)
and a three-carbon alkyl chain, while simultaneously revealing an
unexpected nine aromatic hydrogen atoms between 8.16 and 7.36 ppm
(see the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.chemrestox.5c00068/suppl_file/tx5c00068_si_001.pdf">Supporting Information</ext-link>).</p><fig id="fig2" position="float"><label>Figure 2</label><caption><p>Numbering of
the &#x003b1;-BPVP HCl salt structure.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="tx5c00068_0002" id="gr2" position="float"/></fig><p>Moreover, the <sup>13</sup>C NMR analysis revealed
the presence
of the carbonyl function at 195.9 ppm and the &#x003b1;-carbon to the
carbonyl group at 67.7 ppm. It also confirmed the existence of an
extended aromatic system (139.4&#x02013;127.5 ppm), an alkyl chain
presumably composed of three carbon atoms (at 33.0, 18.3, and 14.0
ppm), and the pyrrolidine ring (2C at lower field 54.1, 52.6 and 2C
at higher ones at 23.6 and 23.5 ppm). This suggested a structure similar
to that of &#x003b1;-PVP, but differing in the aromatic portion.</p><p>Therefore, bidimensional NMR experiments were essential to accurately
assign the structure, better understand the linkage between the aromatic
rings, and verify the other substituents. In particular, the assignments
relied on chemical shifts (&#x003b4;, ppm) for <sup>1</sup>H and <sup>13</sup>C, proton resonance multiplicity patterns determined by <italic>J</italic> couplings (Hz), and correlations observed in the <sup>1</sup>H&#x02013;<sup>1</sup>H (COSY) and <sup>1</sup>H&#x02013;<sup>13</sup>C (HSQC) spectra. Based on the couplings observed in the
COSY and in the HSQC, the propyl chain was confirmed, together with
the presence of a pyrrolidine ring. Notably, the COSY spectrum indicated
an aromatic AA&#x02032;BB&#x02032; system consistent with a para-substituted
aromatic ring alongside a second unsubstituted aromatic ring.</p><p>Moreover, to determine whether the two aromatic rings were connected,
long-range <sup>1</sup>H&#x02013;<sup>13</sup>C correlations were investigated
through HMBC experiments. The carbonyl group at C1 couples with the
para-substituted aromatic ring, as clearly indicated by the coupling
between the carbonyl carbon and H-2&#x02032; and H-6&#x02032; (195.9
and 8.13 ppm). Moreover, C4&#x02032; shows a strong coupling with both
H-2&#x02032; and H-6&#x02032; (148.2 and 8.13 ppm) as well as with H-8&#x02032;
and H-12&#x02032; (148.2 and 7.61 ppm). Similarly, C7&#x02032; couples
with H-8&#x02032; and H-12&#x02032; (139.4 and 7.61 ppm) and with H-3&#x02032;
and H-5&#x02032; (139.4 and 7.76 ppm), demonstrating the linkage between
the aromatic rings to form a biphenyl system.</p><p>At this stage,
an accurate mass analysis became necessary to confirm
the molecular mass of the compound. The analysis was performed using
a QExactive Plus Orbitrap MS (Thermo Fisher Scientific) equipped with
an Ion Max source (Thermo Fisher Scientific). The direct infusion
of the unknown sample in positive full scan mode revealed an <italic>m</italic>/<italic>z</italic> ratio of 308.2021, corresponding to
[M + H]<sup>+</sup>. This is consistent with the elemental composition
of &#x003b1;-BPVP (C<sub>21</sub>H<sub>26</sub>NO<sup>+</sup>) and a
calculated exact mass of 308.2009.</p><p>Considering that NPS follow
similar fragmentation pathways as reported
for synthetic cathinones,<sup><xref ref-type="bibr" rid="ref6">6</xref>,<xref ref-type="bibr" rid="ref7">7</xref></sup> MS/MS experiments were
performed at different collision energies (25, 35, and 50 eV), confirming
that the unknown compound was a synthetic cathinone. Moreover, based
on this fragmentation analogy, it was hypothesized that the molecule
fragments were similar to those reported for the &#x003b1;-PVP (see
the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.chemrestox.5c00068/suppl_file/tx5c00068_si_001.pdf">Supporting Information</ext-link>).</p><p>Specifically,
a fragment with a mass of 237.1274 is observed, likely
due to the loss of the pyrrolidine ring (&#x02212;NC<sub>4</sub>H<sub>9</sub>). The subsequent loss of the alkyl chain generates an ion
with a mass-to-charge ratio (<italic>m</italic>/<italic>z</italic>) of 195.0804. This ion can further rearrange into a substituted
tropylium cation with an <italic>m</italic>/<italic>z</italic> of
167.0855, representing the fragment with the highest intensity. Other
significant fragments included ions with <italic>m</italic>/<italic>z</italic> values of 126.1277 and 84.0808, both attributable to the
portion containing the pyrrolidine ring. This fragmentation pattern
was consistent with that previously observed for the fragmentation
of &#x003b1;-PVP.<sup><xref ref-type="bibr" rid="ref7">7</xref></sup> However, the proposed
fragmentation pattern remains highly speculative, and further investigations
using isotopically labeled molecules would be necessary.</p><p>Finally,
for a complete characterization, the molecule was also
evaluated for optical rotation as well as its melting point. The low
observed optical rotation, close to zero, suggests a mixture of the
two enantiomeric forms, R and S, as indicated on the seized package
with a slight enantiomeric excess of one of the isomers. However,
further HPLC studies using chiral columns are necessary to confirm
this observation. Moreover, the high melting point, ranging between
223 and 228 &#x000b0;C, confirms that the molecule is in its salt form.
To determine the nature of the counterion, preliminary qualitative
assays for halides were performed, which indicated the presence of
chloride ions. The fact that the compound is in its hydrochloride
form was further confirmed by <sup>35</sup>Cl NMR analysis, performed
at 49 MHz, which clearly detected the chloride nucleus (see the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.chemrestox.5c00068/suppl_file/tx5c00068_si_001.pdf">Supporting Information</ext-link>).</p><p>In conclusion,
this represents the identification and complete
characterization of a new substance sold on the illegal market as
a drug with a cathinone-like structure. Further studies on the pharmacological
activity of this molecule and its toxic effects are ongoing.</p><sec id="sec2"><title>Experimental Section</title><p>No unexpected or unusually high
safety hazards were encountered.</p><sec id="sec2.1"><title>Chemicals</title><p>All chemicals and solvents used were of analytical
grade and purchased from Sigma-Aldrich (St. Louis, MO, USA). The <sup>1</sup>H NMR data are tabulated in the following order: multiplicity
(s = singlet, d = doublet, t = triplet, br = broad, m = multiplet,
app = apparent), coupling constant(s) given in hertz, number of protons,
and assignment of proton(s).</p></sec><sec id="sec2.2"><title>Selected Information &#x003b1;-BPVP</title><p>Mp 223&#x02013;228
&#x000b0;C; [&#x003b1;]<sub>D</sub><sup>23</sup> = &#x02212;7.5 (<italic>c</italic> = 1.0 in methanol); <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>/CD<sub>3</sub>OD 1:1 v/v) &#x003b4; = 8.13 (d, <italic>J</italic> = 8.5 Hz, 2H; H-2&#x02032; and H-6&#x02032;), 7.76 (d, <italic>J</italic> = 8.5 Hz, 2H; H-3&#x02032; and H-5&#x02032;), 7.61 (d, <italic>J</italic> = 7.1 Hz, 2H; H-8&#x02032; and H-12&#x02032;), 7.45 (t app, <italic>J</italic> = 7.1 Hz, 2H; H-11&#x02032; and H-9&#x02032;), 7.41&#x02013;7.36
(m,1H; H-10&#x02032;), 5.78 (t app, <italic>J</italic> = 6.0 Hz, 1H;
H-2), 3.71&#x02013;3.60 (overlapping, 2H; H-1&#x02033; or H-4&#x02033;),
3.38&#x02013;3.18 (overlapping, 2H; H-1&#x02033; or H-4&#x02033;), 2.22&#x02013;2.06
(overlapping, 4H; H-2&#x02033; and H-3&#x02033;), 2.06&#x02013;1.96 (overlapping,
2H; H-3a and H-3b), 1.37&#x02013;1.21 (overlapping, 2H; H-4a and H-4b),
0.85 ppm (t, <italic>J</italic> = 7.3 Hz, 3H; H-5); <sup>13</sup>C
NMR (125 MHz, CDCl<sub>3</sub>/CD<sub>3</sub>OD 1:1 v/v) &#x003b4; =
195.9 (C1), 148.2 (C4&#x02032;), 139.4 (C7&#x02032;), 133.4 (C1&#x02032;),
129.9 (2C, C-6&#x02032; and C-2&#x02032;), 129.4 (2C, C-11&#x02032; and
C-9&#x02032;), 129.1 (C10&#x02032;), 128.2 (2C, C-5&#x02032; and C-3&#x02032;),
127.5 (2C, C-12&#x02032; and C-8&#x02032;), 67.7 (C2); 54.1 and 52.6
(2C, C1&#x02033; and C4&#x02033;), 33.0 (C3), 23.6 and 23.5 (2C, C2&#x02033;
and C3&#x02033;), 18.3 (C4), 14.0 ppm (C5); HRMS (HESI/Orbitrap), <italic>m</italic>/<italic>z</italic>, [M + H]<sup>+</sup> Calcd for C<sub>21</sub>H<sub>26</sub>NO<sup>+</sup> 308.2009, Found 308.2021. Complete
information can be found in the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.chemrestox.5c00068/suppl_file/tx5c00068_si_001.pdf">Supporting Information</ext-link>.</p></sec></sec></body><back><notes id="notes1" notes-type="si"><title>Supporting Information Available</title><p>The Supporting Information is
available free of charge at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/10.1021/acs.chemrestox.5c00068?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.chemrestox.5c00068</ext-link>.<list id="silist" list-type="simple"><list-item><p>Material and methods, NMR and, HRMS, GC&#x02013;MS and
HPLC&#x02013;MS spectra (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.chemrestox.5c00068/suppl_file/tx5c00068_si_001.pdf">PDF</ext-link>)</p></list-item></list></p></notes><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="sifile1"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="tx5c00068_si_001.pdf"><caption><p>tx5c00068_si_001.pdf</p></caption></media></supplementary-material></sec><notes notes-type="" id="notes2"><title>Author Contributions</title><p>The manuscript
was written through contributions of all authors. All authors have
given approval to the final version of the manuscript.</p></notes><ack><title>Acknowledgments</title><p>The authors gratefully acknowledge the forensic
chemical investigation unit of the police of Milan for the collaboration.</p></ack><glossary id="dl1"><def-list><title>Abbreviations</title><def-item><term>NPS</term><def><p>new
psychoactive substances</p></def></def-item><def-item><term>&#x003b1;-PVP</term><def><p>&#x003b1;-pyrrolidinopentiophenone</p></def></def-item><def-item><term>&#x003b1;-BPVP</term><def><p>1-([1,1&#x02032;-biphenyl]-4-yl)-2-(pyrrolidin-1-yl)pentan-1-one</p></def></def-item><def-item><term>NMR</term><def><p>Nuclear Magnetic
Resonance</p></def></def-item><def-item><term>HRMS</term><def><p>High-Resolution
Mass Spectrometry</p></def></def-item><def-item><term>GC</term><def><p>Gas Chromatography</p></def></def-item><def-item><term>LC</term><def><p>Liquid Chromatography</p></def></def-item><def-item><term>3,4-MDPHP</term><def><p>3,4-methylenedioxy-&#x003b1;-pyrrolidinohexanophenone</p></def></def-item><def-item><term>3,4-MDPiHP</term><def><p>3,4-methylenedioxy-&#x003b1;-pyrrolidinoisohexanophenone</p></def></def-item><def-item><term>2-MMC</term><def><p>2-methylmethcathinon</p></def></def-item><def-item><term>&#x003b1;-PCYP</term><def><p>&#x003b1;-pyrrolidinocyclohexanophenone</p></def></def-item><def-item><term>COSY</term><def><p>COrrelation SpectroscopY</p></def></def-item><def-item><term>HSQC</term><def><p>Heteronuclear
Single Quantum Coherence</p></def></def-item><def-item><term>HMBC</term><def><p>Heteronuclear Multiple Bond Correlation</p></def></def-item></def-list></glossary><ref-list><title>References</title><ref id="ref1"><mixed-citation publication-type="report" id="cit1"><source>World Drug Report 2024</source>; <publisher-name>United Nations</publisher-name>, <year>2024</year>; <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.unodc.org/unodc/en/data-and-analysis/world-drug-report-2024.html">https://www.unodc.org/unodc/en/data-and-analysis/world-drug-report-2024.html</uri>.</mixed-citation></ref><ref id="ref2"><mixed-citation publication-type="journal" id="cit2"><name><surname>Taflaj</surname><given-names>B.</given-names></name>; <name><surname>La Maida</surname><given-names>N.</given-names></name>; <name><surname>Tittarelli</surname><given-names>R.</given-names></name>; <name><surname>Di Trana</surname><given-names>A.</given-names></name>; <name><surname>D&#x02019;Acquarica</surname><given-names>I.</given-names></name>
<article-title>New Psychoactive
Substances Toxicity: A Systematic Review of Acute and Chronic Psychiatric
Effects</article-title>. <source>Int. J. Mol. Sci.</source>
<year>2024</year>, <volume>25</volume> (<issue>17</issue>), <fpage>9484</fpage><pub-id pub-id-type="doi">10.3390/ijms25179484</pub-id>.<pub-id pub-id-type="pmid">39273431</pub-id>
</mixed-citation></ref><ref id="ref3"><mixed-citation publication-type="journal" id="cit3"><name><surname>Fujiwara</surname><given-names>R.</given-names></name>; <name><surname>Journey</surname><given-names>M.</given-names></name>; <name><surname>Al-Doori</surname><given-names>F.</given-names></name>; <name><surname>Bell</surname><given-names>P.</given-names></name>; <name><surname>Judge</surname><given-names>B.</given-names></name>; <name><surname>Miracle</surname><given-names>K.</given-names></name>; <name><surname>Ito</surname><given-names>K.</given-names></name>; <name><surname>Jones</surname><given-names>S.</given-names></name>
<article-title>Potential Neonatal
Toxicity of New Psychoactive Substances</article-title>. <source>Pharmacol
Ther</source>
<year>2023</year>, <volume>248</volume>, <elocation-id>108468</elocation-id><pub-id pub-id-type="doi">10.1016/j.pharmthera.2023.108468</pub-id>.<pub-id pub-id-type="pmid">37290575</pub-id>
</mixed-citation></ref><ref id="ref4"><mixed-citation publication-type="journal" id="cit4"><name><surname>Shafi</surname><given-names>A.</given-names></name>; <name><surname>Berry</surname><given-names>A. J.</given-names></name>; <name><surname>Sumnall</surname><given-names>H.</given-names></name>; <name><surname>Wood</surname><given-names>D. M.</given-names></name>; <name><surname>Tracy</surname><given-names>D. K.</given-names></name>
<article-title>New Psychoactive
Substances: A Review and Updates</article-title>. <source>Ther Adv.
Psychopharmacol</source>
<year>2020</year>, <pub-id pub-id-type="doi">10.1177/2045125320967197</pub-id>.</mixed-citation></ref><ref id="ref5"><mixed-citation publication-type="report" id="cit5"><source>European Drug Report 2024: Trends and Developments</source>; <publisher-name>EUDA</publisher-name>, <year>2024</year>; <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.euda.europa.eu/publications/european-drug-report/2024_en">https://www.euda.europa.eu/publications/european-drug-report/2024_en</uri>.</mixed-citation></ref><ref id="ref6"><mixed-citation publication-type="journal" id="cit6"><name><surname>Andrenyak</surname><given-names>D. M.</given-names></name>; <name><surname>Moody</surname><given-names>D. E.</given-names></name>; <name><surname>Crites</surname><given-names>J. M.</given-names></name>; <name><surname>Baumann</surname><given-names>M. H.</given-names></name>
<article-title>Analysis for Alpha-Pyrrolidinovalerophenone
and Its 2-Oxo-PVP Metabolite in Plasma by Liquid Chromatography&#x02013;Tandem
Mass Spectrometry</article-title>. <source>J. Anal Toxicol</source>
<year>2021</year>, <volume>45</volume> (<issue>1</issue>), <fpage>21</fpage>&#x02013;<lpage>27</lpage>. <pub-id pub-id-type="doi">10.1093/jat/bkz096</pub-id>.<pub-id pub-id-type="pmid">31776563</pub-id>
</mixed-citation></ref><ref id="ref7"><mixed-citation publication-type="journal" id="cit7"><name><surname>Davidson</surname><given-names>J. T.</given-names></name>; <name><surname>Sasiene</surname><given-names>Z. J.</given-names></name>; <name><surname>Abiedalla</surname><given-names>Y.</given-names></name>; <name><surname>DeRuiter</surname><given-names>J.</given-names></name>; <name><surname>Clark</surname><given-names>C. R.</given-names></name>; <name><surname>Jackson</surname><given-names>G. P.</given-names></name>
<article-title>Fragmentation Pathways
of &#x003b1;-Pyrrolidinophenone
Synthetic Cathinones and Their Application to the Identification of
Emerging Synthetic Cathinone Derivatives</article-title>. <source>Int.
J. Mass Spectrom.</source>
<year>2020</year>, <volume>453</volume>, <elocation-id>116343</elocation-id><pub-id pub-id-type="doi">10.1016/j.ijms.2020.116343</pub-id>.</mixed-citation></ref></ref-list></back></article>